DuPont receives Infant Nutrition Ingredient of the Year Award 2019

Date 05.16.2019 | Category: News
| Comments:

DuPont NH High Potency IDM Mar19

DuPont Nutrition & Biosciences has received the prestigious NutraIngredients Europe "Infant Nutrition Ingredient of the Year Award 2019" for their innovation and commercialization in promoting infant nutrition by supplementing infant and toddler formula with Human Milk Oligosaccharides (HMO) to make it closer to the gold standard of human milk, as well as supporting digestive, immune and cognitive development in infants.


The infant nutrition award was presented at a ceremony in Geneva, Switzerland following Vitafoods Europe and is given for true innovation and cutting-edge research in the nutrition and dietary supplements industries and is an acknowledgement of the industry's very best international health innovation and commercialization.


Said Ratna Mukherjea, Technical Fellow, Technology & Innovation Leader-HMO, DuPont Nutrition & Biosciences: "This win follows last year’s NutraIngredients USA win for CARE4U 2'-FL HMO which again underlines the innovation, research and now commercialization indicating that commercially produced HMOs such as CARE4U can provide some of the health-promoting effects of the HMOs present in human milk, helping to close an important gap between human milk and infant formula."


Steen Lyck, Global Business Director, HMO, who accepted the award alongside Ratna on behalf of DuPont Nutrition & Biosciences, said, "this award is a validation from diverse panel of independent experts confirming the quality of science, innovation and market potential of HMOs in both the infant and toddler formula market. CARE4U is suitable for dietary supplements as well, given that it is one of the highest purity and density HMOs on the market, allowing for smaller dose size and ability to combine with other ingredients."


"The judges said the commercialisation and success seen with the ingredient is a major innovation in the infant nutrition category. They were impressed by the ability to produce the HMO ingredient at a large scale and in a highly pure form, and noted that regulatory approval in the EU and US among other regions, offers big market potential to build on early commercial success,” said Nathan Gray, Senior Editor, NutraIngredients Europe.

"It was a rigorous process including both a written submission and a presentation to the panel of judges and I would like to thank the entire DuPont HMO team on working together on the submission. I also would like to congratulate all our fellow finalists and winners on this momentous achievement,” said Ratna. For more visit or


Source: DuPont
Author: COX
Load more news » Loading news